当前位置:首页 > 股票大全 > 佛慈制药 002644 财务分析

佛慈制药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

佛慈制药(002644)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入274,329,503.971,163,134,313.96860,511,173.37609,032,829.06
营业总成本245,785,793.531,079,170,441.49804,026,862.62553,607,294.29
营业利润22,999,318.6483,274,839.5575,246,927.6169,986,105.7
利润总额22,602,706.181,641,772.7274,294,049.1969,032,731.35
净利润18,641,576.1768,121,997.6859,034,535.1456,842,889.85
其他综合收益--241,981.8838,506.7147,816.37
综合收益总额18,641,576.1767,880,015.859,073,041.8556,890,706.22
佛慈制药(002644)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,252,844,935.251,238,869,322.841,271,079,636.981,297,425,627.66
非流动资产合计1,274,657,410.661,289,232,891.521,291,039,757.431,300,276,014.74
资产总计2,527,502,345.912,528,102,214.362,562,119,394.412,597,701,642.4
流动负债合计462,403,589.12467,687,510.56494,567,059.04526,893,299.84
非流动负债合计278,027,246.13291,984,769.31299,538,882.73304,977,225.55
负债合计740,430,835.25759,672,279.87794,105,941.77831,870,525.39
归属于母公司股东权益合计1,763,758,032.041,745,370,807.771,748,997,238.011,746,936,398.32
股东权益合计1,787,071,510.661,768,429,934.491,768,013,452.641,765,831,117.01
负债和股东权益合计2,527,502,345.912,528,102,214.362,562,119,394.412,597,701,642.4
佛慈制药(002644)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计179,828,915.87977,164,304.36828,915,982.76607,412,494.56
经营活动现金流出小计195,903,367.04911,450,004.5880,136,910.86657,648,776.45
经营活动产生的现金流量净额-16,074,451.1765,714,299.86-51,220,928.1-50,236,281.89
投资活动现金流入小计-9,773,328.778,016,350.698,016,350.69
投资活动现金流出小计2,090,979.343,928,615.1315,213,325.9211,816,919.38
投资活动产生的现金流量净额-2,090,979.3-34,155,286.36-7,196,975.23-3,800,568.69
筹资活动现金流入小计-26,160,00016,160,00016,160,000
筹资活动现金流出小计13,886,666.6751,161,366.6639,695,288.8839,695,288.88
筹资活动产生的现金流量净额-13,886,666.67-25,001,366.66-23,535,288.88-23,535,288.88
汇率变动对现金及现金等价物的影响-674,477.75--
现金及现金等价物净增加额-32,052,097.147,232,124.59-81,953,192.21-77,572,139.46
期末现金及现金等价物余额364,264,596.44396,316,693.58305,731,854.04310,112,906.79
佛慈制药002644相关数据
今日股市大盘指数